The syndrome of delayed post-hypoxic leukoencephalopathy

NeuroRehabilitation

Volumn 26, Issue 1, 2010, Pages 65-72

  Shprecher, David ^a   Mehta, Lahar ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Evergreen Neuroscience Institute   (United States)

Author keywords

Carbon monoxide; Delayed neurologic sequelae; Delayed post anoxic leukoencephalopathy; Delayed post hypoxic encephalopathy

Indexed keywords

AMANTADINE; CARBON MONOXIDE; CENTRAL STIMULANT AGENT; DIMEBON; DONEPEZIL; GALANTAMINE; LEVODOPA; MYELIN BASIC PROTEIN; PLACEBO; RIVASTIGMINE;

ANTICIPATION; AVOIDANCE BEHAVIOR; BED REST; BRAIN HYPOXIA; CARBON MONOXIDE INTOXICATION; CEREBROSPINAL FLUID; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMA; DELAYED POST HYPOXIC LEUKOENCEPHALOPATHY; DELIRIUM; DEMYELINATION; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ELECTROCONVULSIVE THERAPY; HEART INFARCTION; HUMAN; HYPERBARIC OXYGEN; LEUKOENCEPHALOPATHY; MENTAL DISEASE; NEUROIMAGING; NEUROPATHOLOGY; OXYGENATION; PARKINSONISM; PATHOPHYSIOLOGY; PROGNOSIS; PYRAMIDAL TRACT; REVIEW;

ANOXIA; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; LEUKOENCEPHALOPATHIES;

EID: 76649100751     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/NRE-2010-0536     Document Type: Review

References (54)

1. D.B. Arciniegas et al., Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy, Brain Inj 18(12) (2004), 1309-1318.
2. M.P. Barnes and P.K. Newman, Delayed encephalopathy following cardiac arrest, Postgrad Med J 61(713) (1985), 253-254.
3. M.H. Barnett et al., Reversible delayed leukoencephalopathy following intravenous heroin overdose, J Clin Neurosci 8(2) (2001), 165-167.
4. E.E. Benarroch, Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease Neurology 72(20) (2009), 1779-1785.
5. S.D. Brown and C.A. Piantadosi, Reversal of carbon monoxide- cytochrome c oxidase binding by hyperbaric oxygen in vivo, Adv Exp Med Biol 248 (1989), 747-754.
6. Cerebral edema seen in many 'sudden death' heroin victims, Medical News 212(6) (1970), 967.
7. A.S. Chen-Plotkin, K.T. Pau and J.D. Schmahmann, Delayed leukoencephalopathy after hypoxic-ischemic injury, Arch Neurol 65(1) (2008), 144-145.
8. I.S. Choi, Delayed neurologic sequelae in carbon monoxide intoxication, Arch Neurol 40(7) (1983), 433-435.
9. K. Chu et al., Diffusion-weighted MRI and 99mTc-HMPAO SPECT in delayed relapsing type of carbon monoxide poisoning: evidence of delayed cytotoxic edema, Eur Neurol 51(2) (2004), 98-103.
10. C.M. Custodio and J.R. Basford, Delayed postanoxic encephalopathy: a case report and literature review, Arch Phys Med Rehabil 85(3) (2004), 502-505.
11. M.D. Ginsberg, Delayed neurological deterioration following hypoxia, Adv Neurol 26 (1979), 21-44.
12. R. Ginsburg and J. Romano, Carbon monoxide encephalopathy: need for appropriate treatment, Am J Psychiatry 133(3) (1976), 317-320.
13. M.F. Gordon et al., Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus, Mov Disord 10(2) (1995), 220-222.
14. J.A. Gottfried et al., Delayed posthypoxic demyelination. Association with arylsulfatase A deficiency and lactic acidosis on proton MR spectroscopy, Neurology 49(5) (1997), 1400-1404.
15. A. Hori et al., Delayed postanoxic encephalopathy after strangulation. Serial neuroradiological and neurochemical studies, Arch Neurol 48(8) (1991), 871-874.
16. K.A. Josephs et al., Neurologic manifestations in welders with pallidal MRI T1 hyperintensity, Neurology 64(12) (2005), 2033-2039.
17. N. Kawada, N. Ochiai and S. Kuzuhara, Diffusion MRI in acute carbon monoxide poisoning, Intern Med 43(7) (2004), 639-640.
18. C.F. Keogh et al., Neuroimaging features of heroin inhalation toxicity: "chasing the dragon", AJR Am J Roentgenol 180(3), (2003), 847-850.
19. H.Y. Kim et al., Serial diffusion-weighted MR Imaging in delayed postanoxic encephalopathy. A case study, J Neuroradiol 29(3) (2002), 211-215.
20. J.H. Kim et al., Delayed encephalopathy of acute carbon monoxide intoxication: diffusivity of cerebral white matter lesions, AJNR Am J Neuroradiol 24(8) (2003), 1592-1597.
21. K.J. Klos et al., Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity, Arch Neurol 62(9) (2005), 1385-1390.
22. A.R. Kriegstein et al., Leukoencephalopathy and raised brain lactate from heroin vapor inhalation ("chasing the dragon"), Neurology 53(8) (1999), 1765-1773.
23. S.P. Lam et al., Delayed neuropsychiatric impairment after carbon monoxide poisoning from burning charcoal, Hong Kong Med J 10(6) (2004), 428-431.
24. H.B. Lee and C.G. Lyketsos, Delayed post-hypoxic leukoencephalopathy, Psychosomatics 42(6) (2001), 530-533.
25. M.S. Lee and C.D. Marsden, Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings, Mov Disord 9(5) (1994), 550-558.
26. C.A. Mahoney and A.I. Arieff, Uremic encephalopathies: clinical, biochemical, and experimental features, Am J Kidney Dis 2(3) (1982), 324-336.
27. M. Maschke et al., Toxic leukoencephalopathy after intravenous consumption of heroin and cocaine with unexpected clinical recovery, J Neurol 246(9) (1999), 850-851.
28. S.K. Min, A brain syndrome associated with delayed neuropsychiatric sequelae following acute carbon monoxide intoxication, Acta Psychiatr Scand 73(1) (1986), 80-86.
29. T. Mizutani et al., Delayed post-anoxic encephalopathy without relation to carbon monoxide poisoning, Intern Med 32(5) (1993), 430-433.
30. T. Murata et al., Neuronal damage in the interval form of CO poisoning determined by serial diffusion weighted magnetic resonance imaging plus 1H-magnetic resonance spectroscopy, J Neurol Neurosurg Psychiatry 71(2) (2001), 250-253.
31. A.K. Olumbe and A.Y. Kalebi, Death from body packer syndrome: case report, East Afr Med J 81(4) (2004), 218-220.
32. F. Plum and J.B. Posner, Diagnosis of stupor and coma, 1966, Philadelphia: F.A. Davis Co. 128-129.
33. F. Plum, J.B. Posner and R.F. Hain, Delayed neurological deterioration after anoxia, Arch Intern Med 110 (1962), 18-25.
34. J.D. Price and J. Grimley Evans, An N-of-1 randomized controlled trial ('N-of-1 trial') of donepezil in the treatment of non-progressive amnestic syndrome, AgeAgeing 31(4) (2002), 307-309.
35. L.M. Protass, Delayed postanoxic encephalopathy after heroin use, Ann Intern Med 74(5) (1971), 738-739.
36. N. Rizzuto et al., Delayed spongiform leukoencephalopathy after heroin abuse, Acta Neuropathol 94(1) (1997), 87-90.
37. E. Sawyer, L.S. Mauro and M.J. Ohlinger, Amantadine Enhancement of Arousal and Cognition After Traumatic Brain Injury, Ann Pharmacother 42(2) (2008), 247-252.
38. P.W. Schaefer, P.E. Grant and R.G. Gonzalez, Diffusionweighted MR imaging of the brain, Radiology 217(2) (2000), 331-345.
39. C.D. Scheinkestel et al., Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial, Med J Aust 170(5) (1999), 203-210.
40. G. Schlaug et al., Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke, Neurology 49(1) (1997), 113-119.
41. R.N. Sener, Metachromatic leukodystrophy: diffusion MR imaging findings, AJNR Am J Neuroradiol 23(8) (2002), 1424-1426.
42. F. Shillito, C. Drinker and T. Shaughnessy, The problem of nervous and mental sequelae in carbon monoxide poisoning, JAMA 106 (1936), 669-674.
43. D.R. Shprecher et al., Clinical and diagnostic features of delayed hypoxic leukoencephalopathy, J Neuropsychiatry Clin Neurosci 20(4) (2008), 473-477.
44. A.B. Singhal, M.A. Topcuoglu and W.J. Koroshetz, Diffusion MRI in three types of anoxic encephalopathy, J Neurol Sci 196(1-2) (2002), 37-40.
45. T.P. Tan et al., Toxic leukoencephalopathy after inhalation of poisoned heroin: MR findings, AJNR Am J Neuroradiol 15(1) (1994), 175-178.
46. K. Terajima et al., Serial assessments of delayed encephalopathy after carbon monoxide poisoning using magnetic resonance spectroscopy and diffusion tensor imaging on 3.0T system, Eur Neurol 59(1-2) (2008), 55-61.
47. S.R. Thom, Carbon monoxide-mediated brain lipid peroxidation in the rat, J Appl Physiol 68(3) (1990), 997-1003.
48. S.R. Thom et al., Delayed neuropathology after carbon monoxide poisoning is immune-mediated, Proc Natl Acad Sci USA 101(37) (2004), 13660-13665.
49. S.R. Thom, V.M. Bhopale and D. Fisher, Hyperbaric oxygen reduces delayed immune-mediated neuropathology in experimental carbon monoxide toxicity, Toxicol Appl Pharmacol 213(2) (2006), 152-159.
50. Unintentional non-fire-related carbon monoxide exposures - United States, 2001-2003, MMWR Morb Mortal Wkly Rep 54(2) (2005), 36-39.
51. S. Vella et al., Acute leukoencephalopathy after inhalation of a single dose of heroin, Neuropediatrics 34(2) (2003), 100-104.
52. L.K. Weaver et al., Hyperbaric oxygen for acute carbon monoxide poisoning, N Engl J Med 347(14) (2002), 1057-1067.
53. L.M.Weinberger et al., Delayed postanoxic demyelination and arylsulfatase-A pseudodeficiency, Neurology 44(1) (1994), 152-154.
54. S.J.Wolf et al., Clinical policy: Critical issues in the management of adult patients presenting to the emergency department with acute carbon monoxide poisoning, Ann Emerg Med 51(2) (2008), 138-152.